Technology
Health
Biotechnology

Capricor

1,166

$1.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-9.15%) Today
-$0.01 (-0.78%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Capricor and other stocks, options, ETFs, and crypto commission-free!

About CAPR

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. Read More The company was founded in August 2005 and is headquartered in Beverly Hills, CA.

CEO
Linda Marbán
Employees
22
Headquarters
Beverly Hills, California
Founded
2005
Market Cap
9.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.71M
High Today
$1.39
Low Today
$1.21
Open Price
$1.39
Volume
1.17M
52 Week High
$8.85
52 Week Low
$0.2526

Collections

Technology
Health
Biotechnology
Therapy
Medical
US
North America
Female CEOs

CAPR Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$0.34 per share
Actual
-$0.34 per share
Replay Earnings Call

People Also Bought

Onconova Therapeutics

26,201

$0.3101

-3.96%

Onconova Therapeutics

26,201

$0.3101

-3.96%

Biocept

35,002

$0.2846

-7.08%

Titan Pharmaceuticals

35,610

$0.265

+3.72%

Taronis Technologies

19,544

$0.151

-13.71%

You May Also Like

ASM
WLFC
SIEB
ESP
SONG
FISI
TNP
SDAG
QUMU
LMRKO
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy CAPR

Market Price$1.28
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Capricor stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up